RYCEY vs SAFRY: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. RYCEY and SAFRY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined RYCEY and SAFRY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Rolls-Royce Holdings plc is a British industrial company that designs and services large engines and power systems across three businesses. Civil Aerospace makes the Trent family of widebody jet engines (Trent XWB, Trent 7000, Trent 1000) and earns most of its money not from selling engines but from long-term service agreements tied to how many hours those engines fly, so revenue compounds with global air travel. Defence supplies engines and systems for military aircraft, naval vessels and submarines, including the propulsion for nuclear submarine programs, and carries a long order backlog. Power Systems (the MTU brand) builds large diesel and gas engines and generator sets for data centres, marine, defence and industrial use. The company also has a separately run Rolls-Royce SMR unit pursuing small modular nuclear reactors, an emerging long-duration opportunity rather than a current earnings driver.

Full RYCEY guide

Safran SA is a Paris-based aerospace and defense group with about 110,000 employees and roots going back to 1924. Its crown jewel is CFM International, a 50/50 joint venture with GE Aerospace that builds the CFM56 (the engine on most older Boeing 737s and Airbus A320s) and its successor, the LEAP, which powers every Boeing 737 MAX and a majority of Airbus A320neo family jets. Beyond engines, Safran makes landing gear, brakes, nacelles, wiring, power systems, navigation and optronics for defense, and aircraft seats and cabin interiors. In the US it trades as SAFRY, a sponsored ADR on the OTC Pink tier where four ADRs represent one ordinary share listed on Euronext Paris (SAF).

Full SAFRY guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• RYCEY drivers: Aftermarket tied to flying hours; Margin transformation.
• SAFRY drivers: The LEAP installed base and its aftermarket; Margin expansion and cash generation.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Rolls-Royce is a cyclical industrial whose aftermarket profits depend on widebody air travel, so a downturn in long-haul demand, a fuel or travel shock (such as the 2026 jet fuel spike tied to Middle East conflict that hit European airlines), or a fleet grounding would hit the flying-hours revenue that drives the thesis. For SAFRY, the main near-term risk is aftermarket normalization.

Pick RYCEY if you believe its drivers more; SAFRY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the RYCEY and SAFRY guides.

RYCEY. Rolls-Royce reports in pounds sterling and its primary listing is in London (RR.). US investors usually buy it as the over-the-counter RYCEY ADR, so the dollar price reflects both the underlying share and the pound-to-dollar exchange rate, and quoted figures convert from GBP. At $17.99 on October 16, 2026, the ADR trades at about 37 times trailing and 28 times forward earnings and about 29 times EV/EBITDA, a premium industrial multiple that prices in continued margin and cash-flow gains. Analysts expect EPS growth of about 13% in 2027; all figures are approximate and refresh with each result, so verify against Rolls-Royce's investor relations page or your broker.

SAFRY. At ~$76 the ADR prices Safran at a trailing P/E of ~28 and a market value of ~$127 billion, both lower than in February 2026 when the ADR peaked near ~$107. Against 2026 guidance of EUR 6.4 to 6.5 billion in recurring operating income and EUR 4.7 to 4.9 billion of free cash flow, the stock trades at roughly a 4% free cash flow yield. That is still a premium to the broad market but below GE Aerospace's multiple. The rerating reflects worries about 2027 aftermarket growth rather than any guidance cut, since 2026 targets were confirmed in October.

Headline figures (approximate, October 2026): RYCEY shows revenue (ttm to june 2026) ~£23.2 billion, revenue growth (latest period yoy) ~+21%, operating / profit margin (ttm) ~21% / ~13%, net income (ttm) ~£3.0 billion; SAFRY shows adr price (oct 26, 2026) ~$76 (4 ADRs = 1 share), market cap ~$127 billion, revenue (ttm, adjusted) ~EUR 35.3 billion (~$41 billion), recurring operating margin (h1 2026) ~18.4%.

RYCEY and SAFRY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined RYCEY and SAFRY exposure against your real portfolio. It is not an investment adviser.